Patient initiation and persistence with allergen immunotherapy

Annals of Allergy, Asthma and Immunology

Volumn 113, Issue 1, 2014, Pages 101-107

  Anolik, Robert ^a,b   Schwartz, Ann Marie ^a   Sajjan, Shiva ^c   Allen Ramey, Felicia ^c  

^a Allergy and Asthma Specialists   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; NON PRESCRIPTION DRUG; SHORT ACTING DRUG; STEROID;

ADULT; AGE; ALLERGEN IMMUNOTHERAPY; ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ALLERGIC RHINITIS; ANAPHYLAXIS; ARTICLE; ASTHMA; ATTITUDE TO HEALTH; CHRONIC SINUSITIS; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; IMMUNOTHERAPY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; TREATMENT INDICATION; UNITED STATES;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; ASTHMA; CHILD; CHRONIC DISEASE; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS;

EID: 84903164030     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.04.008     Document Type: Article

References (33)

1. M. Schatz A survey of the burden of allergic rhinitis in the USA Allergy 62 suppl 2007 9 16 (Pubitemid 47561568)
2. S.Y. Lin, N. Erekosima, and J.M. Kim et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systemic review JAMA 309 2013 1278 1288
3. P.M. Salo, A. Calatroni, and P.J. Gergen et al. Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006 J Allergy Clin Immunol 127 2011 1226 1235.e7
4. D. Gentile, A. Bartholow, E. Valovirta, G. Scadding, and D. Skoner Current and future directions in pediatric allergic rhinitis J Allergy Clin Immunol Pract 1 2013 214 226
5. A. Burks, M. Calderon, and T. Casale et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report J Allergy Clin Immunol 13 2013 1288 1296
6. P. Ponda, S. Mithani, and Y. Kopyltsova et al. Allergen immunotherapy practice patterns: a worldwide survey Ann Allergy Asthma Immunol 108 2012 454 459.e7
7. J.M. Kim, S.Y. Lin, and C. Suarez-Cuervo et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review Pediatrics 131 2013 1155 1167
8. S.Y. Lin, N. Erekosima, and C. Suarez-Cuervo et al. Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review. Comparative Effectiveness Reviews no 111 2013 Agency for Healthcare Research and Quality Rockville, MD http://www.ncbi.nlm. nih.gov/books/NBK133240/ Accessed July 15, 2013
9. L. Cox, and S. Atwater Allergen immunotherapy for allergic rhinitis and asthma Drug Benefit Trends 20 2008 1 6
10. J. Higgins, and J. Looney Allergen Immunotherapy Am Fam Phys 70 2004 689 696
11. G. Senna, E. Ridolo, M. Calderon, C. Lombardi, G.W. Canonica, and G. Passalacqua Evidence of adherence to allergen-specific immunotherapy Curr Opin Allergy Clin Immunol 9 2009 544 548
12. G.W. Canonica, J. Bousquet, and T. Casale et al. Sub-lingual Immunotherapy. World Allergy Organization Position Paper 2009 World Allergy Organ J 2 2009 233 281
13. C.S. Hankin, L. Cox, and A. Bronston The health economics of allergen immunotherapy Immunol Allergy Clin North Am 31 2011 325 341
14. L. Cox, H. Nelson, and R. Lockey et al. Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 suppl 1 2011 S1 S55
15. G. Passalacqua, V. Garelli, F. Sclifò, and G.W. Canonica Sublingual immunotherapy for allergic rhinitis and conjunctivitis Immunotherapy 5 2013 257 264
16. G. Passalacqua, E. Compalati, and G.W. Canonica Sublingual immunotherapy for allergic rhinitis: an update Curr Opin Otolaryngol Head Neck Surg 19 2011 43 47
17. G. Passalacqua, and G.W. Canonica Allergen-specific sublingual immunotherapy for respiratory allergy Bio Drugs 15 2001 509 519 (Pubitemid 32939229)
18. C. Incorvaia, G.G. Riario-Sforza, S. Incorvaia, and F. Frati Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet Ann Thorac Med 5 2010 128 132
19. L. Cox, and J.R. Cohn Duration of allergen immunotherapy in respiratory allergy: when is enough, enough? Ann Allergy Asthma Immunol 98 2007 416 426 (Pubitemid 46752634)
20. C.S. Hankin, and R.F. Lockey Patient characteristics associated with allergen immunotherapy initiation and adherence J Allergy Clin Immunol 127 2011 46 48
21. R. Vaswani, Y.C. Liu, L. Parikh, and S. Vaswani Inadequate health insurance coverage: a major factor in premature discontinuation of subcutaneous immunotherapy for allergic rhinitis Ear Nose Throat J 90 2011 170 173
22. J. Koberlein, A.C. Kothe, and C. Schaffert Determinants of patient compliance in allergic rhinoconjunctivitis Curr Opin Allergy Clin Immunol 11 2011 192 199
23. D.E. Larenas-Linnemann, P. Gupta, S. Mithani, and P. Ponda Survey on immunotherapy practice patterns: dose, dose adjustments, and duration Ann Allergy Asthma Immunol 108 2012 373 378
24. L. Cox, and D. Wallace Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual Immunol Allergy Clin North Am 31 2011 561 599
25. J.M. Sikora, M.S. Tankersley, A.C.A.A.I. Immunotherapy, and Diagnostics Committee Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey Ann Allergy Asthma Immunol 110 2013 194 197.e4
26. M.H. Tucker, and M.S. Tankersley ACAAI Immunotherapy and Diagnostics Committee. Perception and practice of sublingual immunotherapy among practicing allergists Ann Allergy Asthma Immunol 101 2008 419 425
27. C.S. Hankin, L. Cox, and D. Lang et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs J Allergy Clin Immunol 121 2008 227 232
28. A. Meadows, B. Kaambwa, and N. Novielli et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis Health Technol Assess 17 2013 27
29. M.A. Kiel, E. Röder, and R. Gerth van Wijk et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy J Allergy Clin Immunol 132 2013 353 360.e2
30. J. Sieber, S. De Geest, K. Shah-Hosseini, and R. Mösges Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates Curr Med Res Opin 27 2011 855 861
31. G. Passalacqua, I. Baiardini, G. Senna, and G.W. Canonica Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis Clin Exp Allergy 43 2013 222 228
32. E. Röder, M.Y. Berger, H. de Groot, and R. Gerth van Wijk Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial Clin Exp Allergy 38 2008 1659 1667
33. L. Jacobsen, B. Niggemann, and S. Dreborg et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948 (Pubitemid 47037870)